Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Other Working Capital Changes for 10 consecutive years, with $194000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 96.6% to $194000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, down 119.77% year-over-year, with the annual reading at -$1.1 million for FY2025, 119.77% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was $194000.0 at Rhythm Pharmaceuticals, up from -$1.3 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $5.7 million in Q4 2024, with the low at -$5.2 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$95055.6, with a median of -$121500.0 recorded in 2022.
  • Peak annual rise in Other Working Capital Changes hit 40450.0% in 2024, while the deepest fall reached 1807.04% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $4.9 million in 2021, then plummeted by 177.08% to -$3.8 million in 2022, then tumbled by 37.97% to -$5.2 million in 2023, then surged by 208.81% to $5.7 million in 2024, then plummeted by 96.6% to $194000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $194000.0, -$1.3 million, and $5.7 million for Q4 2025, Q1 2025, and Q4 2024 respectively.